Pan Tao, Zhang Mei, Zhang Fang, Yan Guang, Ru Yi, Wang Qinhao, Zhang Yao, Wei Xuehui, Xu Xinyuan, Shen Lan, Zhang Jian, Wu Kaichun, Yao Libo, Li Xia
The State Key Laboratory of Cancer Biology, Department of Biochemistry and Molecular Biology, The Fourth Military Medical University, Xi'an, Shaanxi Province, China; Xi'an Medical University, Xi'an, Shaanxi Province, China.
The State Key Laboratory of Cancer Biology, Department of Biochemistry and Molecular Biology, The Fourth Military Medical University, Xi'an, Shaanxi Province, China.
Biochem Biophys Res Commun. 2017 Feb 5;483(2):860-866. doi: 10.1016/j.bbrc.2017.01.018. Epub 2017 Jan 7.
Because of the high nutrient consumption and inadequate vascularization, solid tumor constantly undergoes metabolic stress during tumor development. Oncogenes and tumor suppressor genes participated in cancer cells' metabolic reprogramming. N-Myc downstream regulated gene 2 (NDRG2) is a recently identified tumor suppressor gene, but its function in cancer metabolism, particularly during metabolic stress, remains unclear. In this study, we found that NDRG2 overexpression significantly reduced hepatoma cell proliferation and enhanced cell apoptosis under glucose limitation. Moreover, NDRG2 overexpression aggravated energy imbalance and oxidative stress by decreasing the intracellular ATP and NADPH generation and increasing ROS levels. Strikingly, NDRG2 inhibited the activation of fatty acid oxidation (FAO), which preserves ATP and NADPH purveyance in the absence of glucose. Finally, mechanistic investigation showed that NDRG2 overexpression suppressed the glucose-deprivation induced AMPK/ACC pathway activation in hepatoma cells, whereas the expression of a constitutively active form of AMPK abrogated glucose-deprivation induced AMPK activation and cell apoptosis. Thus, as a negative regulator of AMPK, NDRG2 disturbs the induction of FAO genes by glucose limitation, leading to dysregulation of ATP and NADPH, and thus reduces the tolerance of hepatoma cells to glucose limitation.
由于高营养消耗和血管化不足,实体瘤在肿瘤发展过程中不断经历代谢应激。癌基因和肿瘤抑制基因参与癌细胞的代谢重编程。N-Myc下游调控基因2(NDRG2)是最近鉴定出的一种肿瘤抑制基因,但其在癌症代谢中的功能,尤其是在代谢应激期间的功能仍不清楚。在本研究中,我们发现NDRG2过表达在葡萄糖限制条件下显著降低肝癌细胞增殖并增强细胞凋亡。此外,NDRG2过表达通过降低细胞内ATP和NADPH生成以及增加ROS水平,加重能量失衡和氧化应激。令人惊讶的是,NDRG2抑制脂肪酸氧化(FAO)的激活,这在缺乏葡萄糖的情况下维持ATP和NADPH供应。最后,机制研究表明,NDRG2过表达抑制肝癌细胞中葡萄糖剥夺诱导的AMPK/ACC途径激活,而组成型活性形式的AMPK的表达消除了葡萄糖剥夺诱导的AMPK激活和细胞凋亡。因此,作为AMPK的负调节因子,NDRG2干扰葡萄糖限制对FAO基因的诱导,导致ATP和NADPH失调,从而降低肝癌细胞对葡萄糖限制的耐受性。